Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.0 EUR
99.03 M EUR
1.40 B EUR
22.51 M
About TOWA PHARMACEUTICAL CO
Sector
Headquarters
Kadoma
Founded
1951
Website
ISIN
JP3623150004
FIGI
BBG01103SBW9
Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its products include neurological and anti-allergic drugs, cardiovascular and respiratory drugs, gastrointestinal drugs, antibiotics and chemotherapeutic drugs, vitamins; hormone drugs, and other metabolic drugs. The company was founded in June 1951 and is headquartered in Osaka, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6QC is 17.2 EUR — it hasn't changed in the past 24 hours. Watch TOWA PHARMA. CO. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange TOWA PHARMA. CO. stocks are traded under the ticker 6QC.
6QC stock has fallen by −3.39% compared to the previous week, the month change is a −10.00% fall, over the last year TOWA PHARMA. CO. has showed a 12.42% increase.
We've gathered analysts' opinions on TOWA PHARMA. CO. future price: according to them, 6QC price has a max estimate of 23.83 EUR and a min estimate of 19.65 EUR. Watch 6QC chart and read a more detailed TOWA PHARMA. CO. stock forecast: see what analysts think of TOWA PHARMA. CO. and suggest that you do with its stocks.
6QC stock is 0.58% volatile and has beta coefficient of 0.82. Track TOWA PHARMA. CO. stock price on the chart and check out the list of the most volatile stocks — is TOWA PHARMA. CO. there?
Today TOWA PHARMA. CO. has the market capitalization of 849.14 M, it has decreased by −1.96% over the last week.
Yes, you can track TOWA PHARMA. CO. financials in yearly and quarterly reports right on TradingView.
TOWA PHARMA. CO. is going to release the next earnings report on Feb 18, 2025. Keep track of upcoming events with our Earnings Calendar.
6QC earnings for the last quarter are 0.13 EUR per share, whereas the estimation was 0.31 EUR resulting in a −56.61% surprise. The estimated earnings for the next quarter are 0.35 EUR per share. See more details about TOWA PHARMA. CO. earnings.
TOWA PHARMA. CO. revenue for the last quarter amounts to 380.14 M EUR, despite the estimated figure of 362.41 M EUR. In the next quarter, revenue is expected to reach 433.30 M EUR.
6QC net income for the last quarter is 6.62 M EUR, while the quarter before that showed 31.87 M EUR of net income which accounts for −79.22% change. Track more TOWA PHARMA. CO. financial stats to get the full picture.
TOWA PHARMA. CO. dividend yield was 2.07% in 2023, and payout ratio reached 18.26%. The year before the numbers were 3.17% and 134.18% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 4.59 K employees. See our rating of the largest employees — is TOWA PHARMA. CO. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TOWA PHARMA. CO. EBITDA is 249.86 M EUR, and current EBITDA margin is 15.59%. See more stats in TOWA PHARMA. CO. financial statements.
Like other stocks, 6QC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TOWA PHARMA. CO. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TOWA PHARMA. CO. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TOWA PHARMA. CO. stock shows the sell signal. See more of TOWA PHARMA. CO. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.